Aquestive Therapeutics (AQST) Competitors $4.11 +0.10 (+2.49%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$4.36 +0.25 (+5.96%) As of 05:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AQST vs. TWST, TVTX, BHVN, AUPH, SDGR, EVO, JANX, ETNB, EWTX, and WVEShould you be buying Aquestive Therapeutics stock or one of its competitors? The main competitors of Aquestive Therapeutics include Twist Bioscience (TWST), Travere Therapeutics (TVTX), Biohaven (BHVN), Aurinia Pharmaceuticals (AUPH), Schrodinger (SDGR), Evotec (EVO), Janux Therapeutics (JANX), 89BIO (ETNB), Edgewise Therapeutics (EWTX), and WAVE Life Sciences (WVE). These companies are all part of the "pharmaceutical products" industry. Aquestive Therapeutics vs. Its Competitors Twist Bioscience Travere Therapeutics Biohaven Aurinia Pharmaceuticals Schrodinger Evotec Janux Therapeutics 89BIO Edgewise Therapeutics WAVE Life Sciences Twist Bioscience (NASDAQ:TWST) and Aquestive Therapeutics (NASDAQ:AQST) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation. Which has more volatility and risk, TWST or AQST? Twist Bioscience has a beta of 2.36, suggesting that its stock price is 136% more volatile than the S&P 500. Comparatively, Aquestive Therapeutics has a beta of 1.99, suggesting that its stock price is 99% more volatile than the S&P 500. Is TWST or AQST more profitable? Twist Bioscience has a net margin of -23.51% compared to Aquestive Therapeutics' net margin of -147.38%. Aquestive Therapeutics' return on equity of 0.00% beat Twist Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-23.51% -29.03% -21.77% Aquestive Therapeutics -147.38%N/A -63.87% Do institutionals and insiders hold more shares of TWST or AQST? 32.5% of Aquestive Therapeutics shares are held by institutional investors. 3.0% of Twist Bioscience shares are held by company insiders. Comparatively, 8.4% of Aquestive Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts recommend TWST or AQST? Twist Bioscience currently has a consensus target price of $49.40, suggesting a potential upside of 71.29%. Aquestive Therapeutics has a consensus target price of $10.14, suggesting a potential upside of 146.78%. Given Aquestive Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Aquestive Therapeutics is more favorable than Twist Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.73Aquestive Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, TWST or AQST? Aquestive Therapeutics has lower revenue, but higher earnings than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Aquestive Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$312.97M5.56-$208.73M-$1.45-19.89Aquestive Therapeutics$57.56M7.12-$44.14M-$0.70-5.87 Does the media prefer TWST or AQST? In the previous week, Aquestive Therapeutics had 13 more articles in the media than Twist Bioscience. MarketBeat recorded 20 mentions for Aquestive Therapeutics and 7 mentions for Twist Bioscience. Twist Bioscience's average media sentiment score of 0.75 beat Aquestive Therapeutics' score of 0.38 indicating that Twist Bioscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aquestive Therapeutics 2 Very Positive mention(s) 3 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAquestive Therapeutics beats Twist Bioscience on 10 of the 16 factors compared between the two stocks. Get Aquestive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AQST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AQST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AQST vs. The Competition Export to ExcelMetricAquestive TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$399.89M$2.48B$5.61B$9.84BDividend YieldN/A1.76%4.61%4.07%P/E Ratio-5.8722.0530.2725.74Price / Sales7.12742.42459.75115.79Price / CashN/A184.4138.2159.48Price / Book-5.634.838.846.15Net Income-$44.14M$31.61M$3.25B$265.06M7 Day Performance5.38%4.55%3.72%2.60%1 Month Performance2.24%5.69%5.86%2.83%1 Year Performance-0.24%12.71%30.25%25.58% Aquestive Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AQSTAquestive Therapeutics2.0677 of 5 stars$4.11+2.5%$10.14+146.8%+6.5%$399.89M$57.56M-5.87160News CoverageEarnings ReportHigh Trading VolumeTWSTTwist Bioscience4.0257 of 5 stars$27.63+7.8%$49.40+78.8%-32.3%$1.55B$312.97M0.00990TVTXTravere Therapeutics2.7228 of 5 stars$17.28+2.0%$32.21+86.4%+113.7%$1.51B$233.18M-8.47460Positive NewsBHVNBiohaven3.5669 of 5 stars$13.42-8.9%$58.46+335.5%-62.7%$1.51BN/A-1.43239Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap DownAUPHAurinia Pharmaceuticals2.8409 of 5 stars$11.43+0.5%$12.00+5.0%+116.3%$1.50B$235.13M26.58300Positive NewsSDGRSchrodinger3.2614 of 5 stars$18.63-3.0%$32.75+75.8%+2.4%$1.41B$207.54M-7.51790News CoverageAnalyst ForecastGap DownEVOEvotec1.8134 of 5 stars$3.81-3.1%$5.90+54.9%+15.4%$1.40B$862.40M0.004,827Trending NewsAnalyst ForecastJANXJanux Therapeutics2.3955 of 5 stars$22.67-0.7%$91.89+305.3%-37.8%$1.37B$10.59M0.0030News CoverageAnalyst RevisionETNB89BIO1.9342 of 5 stars$8.77-4.3%$26.29+199.7%+19.0%$1.34BN/A0.0040News CoverageAnalyst ForecastEWTXEdgewise Therapeutics2.2737 of 5 stars$12.99+2.4%$40.64+212.8%-18.3%$1.34BN/A0.0060News CoverageInsider TradeWVEWAVE Life Sciences4.7518 of 5 stars$8.10+0.1%$20.27+150.2%+60.0%$1.29B$108.30M-9.00240Gap Down Related Companies and Tools Related Companies TWST Alternatives TVTX Alternatives BHVN Alternatives AUPH Alternatives SDGR Alternatives EVO Alternatives JANX Alternatives ETNB Alternatives EWTX Alternatives WVE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AQST) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aquestive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aquestive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access